Mills, Richard
Hudson, James
Article History
First Online: 14 April 2020
Competing interests
: R.M. and J.H. have collaborated with AstraZeneca for the discovery of new heart-failure drugs, are on the scientific advisory board of Dynomics for the discovery of new heart-failure drugs, and have patents related to bioengineered-tissue technologies and culture conditions, and to putative therapeutic targets for heart failure.